75 completed, 3 unknown, 3 withdrawn, 2 recruiting. 85 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 85 | Completed 75, Unknown 3, Withdrawn 3, Recruiting 2, Active not recruiting 1, Terminated 1 |
| Phase 2 | 4 | Completed 2, Unknown 2 |
Follow Fasting: new trials by email Literature Review of Fasting trials Research Report on Fasting
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Time Restricted Eating in Patients With Microalbuminuria Time Restricted Eating - Type 2 Diabetes Mellitus (T2DM), Time Restricted Eating | Phase 1 | Recruiting | University of California, San Diego | 25 | 2026-07-01 | 2026-07-14 |
| The Food Effect on Pharmacokinetics of Fixed Dose Combination of Gemigliptin/Dapagliflozin/Metformin in Healthy Volunteers Fixed-dose combination of gemigliptin/dapagliflozin/metformin 50/10/1000 mg - Healthy, Fasting | Phase 1 | Completed | LG Chem | 28 | 2026-06-11 | 2026-09-10 |
| Pharmacokinetics of Zelquistinel in Fasted or Fed State Zelquistinel 3 mg, Zelquistinel 10 mg - Healthy Volunteers in Fed and Fasted State | Phase 1 | Active not recruiting | Syndeio Biosciences, Inc | 32 | 2025-07-24 | 2026-03-20 |
| A Study to Investigate the Effect of Food on Balcinrenone/Dapagliflozin Pharmacokinetics in Fed and Fasted State and Pharmacokinetics of Balcinrenone When Dosed With a P-gp Inhibitor in Healthy Participants. balcinrenone/ dapagliflozin, quinidine - Healthy Participants | Phase 1 | Completed | AstraZeneca | 14 | 2025-05-20 | 2025-08-12 |
| TREAD: Time Restricted Eating Intervention for Alzheimer's Disease Time-restricted eating - Mild Cognitive Impairment, Alzheimer Disease | Phase 1 | Recruiting | University of California, San Diego | 60 | 2025-04-23 | 2026-05-26 |
| In-clinic Crossover Study in Subjects With Two Treatments (Fed vs Fasted) Dexmethylphenidate - Healthy Volunteers in Fed and Fasted State | Phase 1 | Completed | Cingulate Therapeutics | 25 | 2024-10-31 | 2025-08-12 |
| Bioequivalence Study of Sulfadoxine/Pyrimethamine 500/25 mg Dispersible Tablet Sulfadoxine 500 MG / Pyrimethamine 25 MG dispersible tablets., Sulfadoxine 500 MG / Pyrimethamine 25 MG dispersible tablets in SPAQ - Fasting | Phase 1 | Unknown | Swiss Pharma Nigeria Limited | 46 | 2024-07-01 | 2024-07-26 |
| Single-dose, Two-way Crossover Bioequivalence of Lamotrigine in Healthy Male Volunteers Under Fasting Conditions Lamotrigine 100 MG - Fasting | Phase 1 | Completed | Desitin Arzneimittel GmbH | 24 | 2023-04-03 | 2024-01-10 |
| Fed-Fast Crossover Study to Assess the Effect of Food With CTx-1301 in Healthy Subjects Dexmethylphenidate - Healthy Volunteers in Fed and Fasted State | Phase 1 | Completed | Cingulate Therapeutics | 27 | 2022-09-14 | 2022-10-20 |
| Bioequivalence Study of Rivaroxaban 2.5 mg Tablets Under Fasting and Fed Conditions Rivaroxaban 2.5 mg Test Tablet, Rivaroxaban 2.5 mg Reference Tablet - Healthy Participants | Phase 1 | Completed | The Affiliated Hospital of Qingdao University | 64 | 2022-03-16 | 2026-09-08 |
| CD19 and BCMA Targeted Fast Dual CAR-T for CD19+ Refractory/Relapsed B-NHL Fast Dual CAR-T Injection - B-cell Lymphoma | Phase 1 | Withdrawn | 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | 2021-05-05 | 2023-02-10 | |
| Intermittent Fasting and CLL/SLL Intermittent fast - Neoplasms, Leukemia, Lymphocytic, Chronic | Phase 1 | Completed | Eleah Stringer | 15 | 2021-02-03 | 2023-02-14 |
| Fighting Immunosenescence and Promoting Immunity by a Fasting-mimicking Diet Elderly. Prolon - FMD - Frailty, Inflammation | Phase 1 / Phase 2 | Unknown | University of Genova | 40 | 2020-09-15 | 2021-10-25 |
| Proton Pump Inhibitors Effects on Dyspepsia During Ramadan Fasting Esomeprazole, Placebo - Dyspepsia | Phase 1 / Phase 2 | Completed | University of Monastir | 500 | 2020-01-20 | 2025-02-25 |
| A Study on the Bioequivalence of Perindopril Tert-butylamine Tablets Taken on an Empty Stomach in Healthy Subjects Perindopril tert-Butylamine tablets （ Produced by Haisco）, Perindopril tert-Butylamine tablets（ACERTIL®） - Healthy | Phase 1 | Completed | Sichuan Haisco Pharmaceutical Group Co., Ltd | 32 | 2018-11-29 | 2020-09-21 |
| Bioequivalence Study of Bosentan 125 mg Tablets Immediate Release (IR) Versus Tracleer® 125 mg Tablets IR In Healthy Subjects Bosentan 125 mg, Tracleer 125Mg Tablet - Bioequivalence | Phase 1 | Completed | Geropharm | 64 | 2018-05-24 | 2019-09-24 |
| Pharmacokinetics Study of Eplerenone Coated Tablets eplerenone - Pharmacokinetics, Healthy Subjects | Phase 1 | Withdrawn | Biolab Sanus Farmaceutica | 2017-07-01 | 2018-06-06 | |
| Bioequivalence Study of Metformin 750 mg Tablets XR Versus Glucophage® Long 750 mg Tablets XR In Normal Healthy Subjects Under Fasting and Fed Conditions Metformine, Glucophage® Long, Metformin - Bioequivalence | Phase 1 | Completed | Geropharm | 28 | 2017-06-15 | 2018-07-03 |
| Bioequivalence Study of Metformin 1000 mg Tablets Immediate Release (IR) Versus Glucophage® 1000 mg Tablets IR In Healthy Subjects Metformin, Glucophage® - Bioequivalence | Phase 1 | Completed | Geropharm | 18 | 2017-02-14 | 2018-07-03 |
| The Effect of Time-restricted Feeding on Physiological Function in Middle-aged and Older Adults Time Restricted Feeding - Aging | Phase 1 / Phase 2 | Unknown | University of Colorado, Boulder | 12 | 2016-04-01 | 2019-06-14 |
Showing 20 of 85. Sign in to see all of them.
Lecithin Cholesterol Acyltransferase Deficiency (10) · Intermittent Fasting (4) · Inflammation (2) · Alzheimer Disease (1) · Cardiovascular Diseases (1) · Cognitive Dysfunction (1) · Diabetes Mellitus, Type 2 (1) · Dyspepsia (1) · Feeding Behavior (1) · Frailty (1) · Immune System Diseases (1) · Insulin Resistance (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Liver Cirrhosis (1)
Behavior (85) · Feeding Behavior (84) · Metabolic Diseases (11) · Nutritional and Metabolic Diseases (11) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (10) · Dyslipidemias (10) · Genetic Diseases, Inborn (10) · Hypoalphalipoproteinemias (10) · Hypolipoproteinemias (10) · Lipid Metabolism Disorders (10) · Lipid Metabolism, Inborn Errors (10) · Metabolism, Inborn Errors (10) · Pathological Conditions, Signs and Symptoms (5) · Pathologic Processes (4)
Doxycycline (3) · Lisinopril (3) · Metformin (3) · Ondansetron (3) · Clonazepam (2) · Clopidogrel (2) · Dexmethylphenidate Hydrochloride (2) · Dronabinol (2) · Etodolac (2) · Hydrochlorothiazide (2) · Metoprolol (2) · Olanzapine (2) · Tablets (2) · dapagliflozin (2) · recombinant methionyl human leptin (2)
Par Pharmaceutical, Inc. (18) · Dr. Reddy's Laboratories Limited (12) · IPCA Laboratories Ltd. (12) · AstraZeneca (3) · Geropharm (3) · GlaxoSmithKline (3) · Beth Israel Deaconess Medical Center (2) · Cingulate Therapeutics (2) · Desitin Arzneimittel GmbH (2) · Mutual Pharmaceutical Company, Inc. (2) · Pfizer (2) · University of California, San Diego (2) · 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China (1) · Actavis Inc. (1) · Biolab Sanus Farmaceutica (1)
United States (21) · India (20) · Canada (14) · Russia (3) · United Kingdom (3) · China (2) · Jordan (2) · Belgium (1) · Brazil (1) · Bulgaria (1) · Germany (1) · Indonesia (1) · Ireland (1) · Italy (1) · Japan (1)
Dr. Hardik Dave, M.B.B.S (4) · Eric Masson, Pharm.D. (3) · Anthony R Godfrey, Pharm.D. (2) · Christian Aumais (2) · Dr. Hardik Dave, M.B.B.S. (2) · Gary Shillito (2) · Matt Brams, MD (2) · Ali Ziaee (1) · Antonio Pizzaro (1) · Antonio R. Pizarro, M.D., (1) · Benoit Girard, M.D. (1) · Christian Sicard, M.D (1) · Christopher R Martens, Ph.D. (1)
PMID 21917874, PMID 33051459, PMID 35820631, PMID 18201934, PMID 20703446, PMID 21045179, PMID 21660636, PMID 22775199, PMID 23193213, PMID 23713767, PMID 25540981, PMID 25613340, PMID 29856004, PMID 30479286, PMID 33512717, PMID 35061234, PMID 39097160, PMID 41120363
M01RR001032 (1), R01DK058785 (1), R44CA143716 (1), R61AG085253 (1)